Suppr超能文献

与急性髓系白血病预后良好相关的 microRNAs 及其对巨噬细胞极化的影响。

MicroRNAs Associated With a Good Prognosis of Acute Myeloid Leukemia and Their Effect on Macrophage Polarization.

机构信息

Department of Hematology, Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.

Department of Hematology, Brest University Medical School Hospital, Brest, France.

出版信息

Front Immunol. 2021 Jan 15;11:582915. doi: 10.3389/fimmu.2020.582915. eCollection 2020.

Abstract

Acute myeloid leukemia (AML) is an aggressive myeloid malignancy with poor outcomes despite very intensive therapeutic approaches. For the majority of patients which are unfit and treated less intensively, the prognosis is even worse. There has been unspectacular progress in outcome improvement over the last decades and the development of new approaches is of tremendous interest. The tumor microenvironment is credited with an important role in supporting cancer growth, including leukemogenesis. Macrophages are part of the tumor microenvironment and their contribution in this setting is increasingly being deciphered, these cells being credited with a tumor supporting role. Data on macrophage role and polarization in leukemia is scarce. MicroRNAs (miRNAs) have a role in the post-transcriptional regulation of gene expression, by impending translation and promoting degradation of messenger RNAs. They are important modulators of cellular pathways, playing major roles in normal hematopoietic differentiation. miRNA expression is significantly correlated with the prognosis of hematopoietic malignancies, including AML. Oncogenic miRNAs correlate with poor prognosis, while tumor suppressor miRNAs, which inhibit the expression of proto-oncogenes, are correlated with a favorable prognosis. miRNAs are proposed as biomarkers for diagnosis and prognosis and are regarded as therapeutic approaches in many cancers, including AML. miRNAs with epigenetic or modulatory activity, as well as with synergistic activity with chemotherapeutic agents, proved to be promising therapeutic targets in experimental, pre-clinical approaches. The clinical availability of emerging compounds with mimicking or suppressor activity provides the opportunity for future therapeutic targeting of miRNAs. The present paper is focusing on miRNAs which, according to current knowledge, favorably impact on AML outcomes, being regarded as tumor suppressors, and reviews their role in macrophage polarization. We are focusing on miRNA expression in the setting of AML, but data on correlations between miRNA expression and macrophage polarization is mostly coming from studies involving normal tissue.

摘要

急性髓细胞白血病(AML)是一种侵袭性髓系恶性肿瘤,尽管采用了非常强化的治疗方法,但预后仍较差。对于大多数不适合接受更强化治疗的患者,预后甚至更差。在过去几十年中,在改善预后方面进展甚微,因此开发新方法具有巨大的意义。肿瘤微环境被认为在支持癌症生长方面发挥着重要作用,包括白血病的发生。巨噬细胞是肿瘤微环境的一部分,它们在这种环境中的作用正逐渐被揭示,这些细胞被认为具有支持肿瘤的作用。关于巨噬细胞在白血病中的作用和极化的数据很少。微小 RNA(miRNA)在基因表达的转录后调控中具有作用,通过抑制翻译和促进信使 RNA 的降解。它们是细胞途径的重要调节剂,在正常造血分化中发挥重要作用。miRNA 的表达与造血恶性肿瘤的预后显著相关,包括 AML。致癌 miRNA 与预后不良相关,而肿瘤抑制 miRNA 抑制原癌基因的表达,与预后良好相关。miRNA 被认为是诊断和预后的生物标志物,并在许多癌症中被认为是治疗方法,包括 AML。具有表观遗传或调节活性以及与化疗药物协同活性的 miRNA 已被证明是实验性、临床前方法中很有前途的治疗靶点。新兴化合物具有模拟或抑制活性,为未来 miRNA 的治疗靶向提供了机会。本文重点介绍了根据目前的知识,对 AML 结果有积极影响的 miRNA,被认为是肿瘤抑制因子,并综述了它们在巨噬细胞极化中的作用。我们重点介绍了 AML 中 miRNA 的表达,但 miRNA 表达与巨噬细胞极化之间的相关性数据主要来自涉及正常组织的研究。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验